Cypherpunk Technologies/$CYPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cypherpunk Technologies
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
Ticker
$CYPH
Sector
Primary listing
Employees
6
Headquarters
Website
CYPH Metrics
BasicAdvanced
$123m
-
-$0.58
-0.10
-
Price and volume
Market cap
$123m
Beta
-0.1
52-week high
$3.70
52-week low
$0.23
Average daily volume
4m
Financial strength
Current ratio
27.28
Quick ratio
27.024
Total debt to equity
0.045
Interest coverage (TTM)
-1,026.08%
Profitability
Effective tax rate (TTM)
-0.24%
Management effectiveness
Return on assets (TTM)
-26.23%
Return on equity (TTM)
-108.18%
Valuation
Price to book
1.29
Price to tangible book (TTM)
1.29
Price to free cash flow (TTM)
-3.455
Free cash flow yield (TTM)
-28.94%
Free cash flow per share (TTM)
-0.336
Growth
Earnings per share change (TTM)
-65.63%
3-year earnings per share growth (CAGR)
-57.05%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs